Xiaofeng Zhou, PhD

Sr. Director
Pfizer, Inc.

Poster(s):

• (094) Concomitant prescribing of nirmatrelvir/ritonavir (NMV-r) and medications with potential risk for drug-drug interaction – a feasibility assessment of Truveta Electronic Health Records Database.
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (ASPOT08) Towards a Framework to Describe Diversity of Real-World Data Sources: Findings from the DIVERSE Initiative
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST